Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
+0.9%/yr
vs -5.2%/yr prior
5Y CAGR
+8.5%/yr
Recent deceleration
Acceleration
+6.1pp
Accelerating
Percentile
P44
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 81.70% | -0.2% |
| 2024 | 81.86% | -0.8% |
| 2023 | 82.52% | +3.8% |
| 2022 | 79.47% | +8.6% |
| 2021 | 73.14% | +34.6% |
| 2020 | 54.35% | +32.2% |
| 2019 | 41.11% | -58.2% |
| 2018 | 98.30% | -1.5% |
| 2017 | 99.74% | +0.5% |
| 2016 | 99.26% | - |